Corrigendum
Steven G. Potkin, Tatsuya Kimura and John Guarino. A 6-week, double-blind, placebo- and haloperidol-controlled, phase II study of lurasidone in patients with acute schizophrenia. Therapeutic Advances in Psychopharmacology 2045125315606027, first published on October 9, 2015. [Doi: 10.1177/2045125315...
Gespeichert in:
| Veröffentlicht in: | Therapeutic advances in psychopharmacology 2015-12, Vol.5 (6), p.369-369 |
|---|---|
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | Steven G. Potkin, Tatsuya Kimura and John Guarino. A 6-week, double-blind, placebo- and haloperidol-controlled, phase II study of lurasidone in patients with acute schizophrenia. Therapeutic Advances in Psychopharmacology 2045125315606027, first published on October 9, 2015. [Doi:
10.1177/2045125315606027
] |
|---|---|
| ISSN: | 2045-1253 2045-1261 |
| DOI: | 10.1177/2045125315621242 |